Citation Impact
Citing Papers
TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription
2007
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
The Circadian Clock Controls Sunburn Apoptosis and Erythema in Mouse Skin
2014 StandoutNobel
Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation
2015 Standout
Circadian Clocks in Mouse and Human CD4+ T Cells
2011
Are Circadian Rhythms the Code of Hypothalamic-Immune Communication? Insights from Natural Killer Cells
2007
Transcriptional architecture of the mammalian circadian clock
2016 Standout
Operating Room Managerial Decision-Making on the Day of Surgery With and Without Computer Recommendations and Status Displays
2007
Epigenetics: A Landscape Takes Shape
2007 Standout
Neutrophils at work
2014 Standout
Epigenetic therapy of cancer: past, present and future
2006
Adrenergic Nerves Govern Circadian Leukocyte Recruitment to Tissues
2012
Histone Deacetylase Inhibitors and Demethylating Agents: Clinical Development of Histone Deacetylase Inhibitors for Cancer Therapy
2007
Cancer stem cells revisited
2017 Standout
The Epigenomics of Cancer
2007 Standout
DIURNAL VARIATION IN ENDOTOXIN-INDUCED MORTALITY IN MICE: CORRELATION WITH PROINFLAMMATORY FACTORS
2009
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors
2004
Epigenetics in Cancer
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Histone deacetylase inhibitors as new cancer drugs
2001
Epigenetics in cancer
2009 Standout
Cancer genes and the pathways they control
2004 Standout
Histone deacetylation in epigenetics: An attractive target for anticancer therapy
2005
The adrenal peripheral clock: Glucocorticoid and the circadian timing system
2011
Sleep Deprivation Effects on Circadian Clock Gene Expression in the Cerebral Cortex Parallel Electroencephalographic Differences among Mouse Strains
2008 StandoutNobel
Polymer conjugates as anticancer nanomedicines
2006 Standout
FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells
2003
Histone deacetylase inhibitors: from target to clinical trials
2002
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Circadian control of the immune system
2013 Standout
Histone deacetylases and cancer: causes and therapies
2001 Standout
Epigenetic treatment of solid tumours: a review of clinical trials
2015
Modulation of cellular radiation responses by histone deacetylase inhibitors
2006
Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer
2001
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
The Multiple Facets of Per2
2007
Apoptosis
2002 Standout
Oxidative stress and redox regulation of lung inflammation in COPD
2006 Standout
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Overview of the clinical efficacy of investigational anticancer drugs
2003
Circadian Clock Proteins and Immunity
2014
Interactions of the circadian CLOCK system and the HPA axis
2010
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Timing to Perfection: The Biology of Central and Peripheral Circadian Clocks
2012
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
2008
Sex differences in immune responses
2016 Standout
Histone deacetylase inhibitors in clinical development
2004
Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity
2007
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Histone Deacetylase Inhibitors
2004
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
2004 Standout
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
2004
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Dual modes of CLOCK:BMAL1 inhibition mediated by Cryptochrome and Period proteins in the mammalian circadian clock
2014 StandoutNobel
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
2006 Standout
Sleep, Immunity, and Circadian Clocks: A Mechanistic Model
2010
AMPK: a nutrient and energy sensor that maintains energy homeostasis
2012 Standout
Crosstalk between the circadian clock circuitry and the immune system
2013
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor
2004
Environmental epigenomics and disease susceptibility
2007 Standout
The dawning era of polymer therapeutics
2003 Standout
Chromatin, cancer and drug therapies
2008
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Operating room planning and scheduling: A literature review
2009 Standout
A circadian clock in macrophages controls inflammatory immune responses
2009
Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
2005
Review: Advances in Intraperitoneal (Intracavitary) Administration of Synthetic Polymers for Immunotherapy and Chemotherapy
1986
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity
1986
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Regulation Mechanisms and Signaling Pathways of Autophagy
2009 Standout
Clinical Science Review: The Routinization of Intraperitoneal (Intracavitary) Chemotherapy and Immunotherapy
1986
Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.
2002
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
2015
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
About Sleep's Role in Memory
2013 Standout
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Histone Deacetylase Inhibitors
2003
Epigenetic regulation of redox state mediates persistent cardiorespiratory abnormalities after long‐term intermittent hypoxia
2016 StandoutNobel
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
2003
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
2004 Standout
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
2004
Works of Mark Meyer being referenced
The Circadian ClockPeriod 2Gene Regulates Gamma Interferon Production of NK Cells in Host Response to Lipopolysaccharide-Induced Endotoxic Shock
2006
INCOMING!—A Web Tracking Application for PACU and Post-Surgical Patients
2006
Chronic Oral Administration of CI-994: A Phase I Study
2001
Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system
1984